Navigation Links
Tilt Adapter +- 8 Degrees

ProductsTilt Adapter +- 8 Degrees
Company myNeuroLab.com
Item Tilt Adapter +- 8 Degrees
Features Inquire
Description Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen.
Info myNeuroLab.com
Customer Service: (866) 444-0944
Web site: http://www.myneurolab.com

Related medicine products :

1. Luminary ACMI Light Probe Adapter
2. EasyView Slit Lamp Adapter
3. Pin Adapter Set
4. Universal I/A handpiece - Stainless steel (Luer Adapter Tip)
5. Amplifier Adapter
6. Digital-Photo Adapter DC 01
7. PenAdapt - Electrosurgical Pencil Adapter For The Collection Of Smoke Plume
8. Autoclavable Light Guides & Adapters
9. SureCut M3500 Specimen Orientation Adapter
10. Glass Knife Adapter
11. V-Block Adapter
Other Medicine News:Health News:British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues 2Health News:British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues 3Health News:British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues 4Health News:British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues 5Health News:Scientists reveal DNA-enzyme interaction with first ever real time footage 2Health News:Milestone Scientific to Exhibit the STA(TM) System at the American Dental Association's 148th Annual Session in San Francisco 2Health News:Milestone Scientific to Exhibit the STA(TM) System at the American Dental Association's 148th Annual Session in San Francisco 3Health News:Study finds limiting work hours for surgical residents enhances training 2Health News:Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research 2Health News:Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research 3Health News:OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program 2
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 4Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 1Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 2Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 3Osseon Receives CE Mark 57784 1Osseon Receives CE Mark 57784 2